Since a study found some anti-fibrotic effects of CCL2 inhibitor in animal models of liver fibrosis (30), the pathway of CCL2/CCR2 as potential therapeutic targets should be further investigated by future studies. The gene discussed is CCL2; the disease is Hepatic fibrosis.